HSIC - Henry Schein's Transition From Distributor To Manufacturer Spurs Upgrade - This Analyst Sees Easing Headwinds | Benzinga
Stifel analyst Jonathan D. Block upgraded health care products distributor Henry Schein Inc (NASDAQ: HSIC) to Buy from Hold and maintained a price target of $70.
The analyst is bullish as the impact of several multi-year headwinds, including the pace of practice consolidation and loss of market share to pure online providers, are diminishing.
Although the recent (and ongoing) cybersecurity incident is of concern, the analyst says that near-term resolution can modestly impact market share and drive ...